Agenda Details

Learn more about sessions and presentations at the 25th Annual Meeting

Detailed Program

Part 1: Translating Science Into Medicine: Moving from Bench to Startup (Organized by the Bioindustry & Translational Science Committees)

There is often intriguing research or early proof-of-concept data with a cell & gene therapy product that seems ‘almost perfect’ for developing into a therapeutic for human use. The problem becomes how does one go about building a program to continually de-risk the product opportunity for transition from bench to bedside on the scientific side as well as forming / financing / building out a company focused on the transition toward a first-in-human clinical trial under a commercial IND filing. This is a two-part symposium intended to gain an understanding of “Translating Translational Medicine” in practice.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.